Get startedLog in
    Picture of Prophase Labs logo

    PRPH — Prophase Labs News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    All News

    Brief: DSS Announces Licensing Of Impact Biomedical’s Linebacker Portfolio To Prophase Labs

    Picture of Prophase Labs logoProphase Labs
    21/07/2022 22:16
    July 21 (Reuters) - DSS Inc  DSS.A :
    * DSS ANNOUNCES LICENSING OF IMPACT BIOMEDICAL’S LINEBACKER
PORTFOLIO TO PROPHASE LABS

Source text for Eikon:  ID:nGNX4H6VmB 
Further company coverage:  DSS.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Prophase Labs

    See all news